Loading...
NPI 1013917665 · Plainview, NY · Dermatology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Bijan Setareh-shenas is a dermatology physician provider located in Plainview, New York. This profile covers 30 Medicare and 16 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Bijan Setareh-shenas |
| Address | 700 Old Country Rd |
| City | Plainview |
| State | NY |
| ZIP | 11803 |
| Taxonomy | Dermatology Physician |
| NPI Enumerated | July 26, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $2.8M |
| Medicare | $1.4M |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
30 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 17108 | Cutaneous vascular destruction is generally performed with a laser (e.g. Argon, pulsed dye, and YAG). This is a bloodless surgery due to the fact that there is no incision made in the skin. This… | 360 | $620 | $224.6K |
| 17004 | The provider destroys 15 or more premalignant lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. | 1,120 | $150 | $168K |
| 96574 | This code is used to report removal of hyperkeratotic (hardened, dry, scaly) skin lesions that appear precancerous followed by photodynamic therapy that exposes a lesion treated with a… | 600 | $270 | $160.7K |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 120,600 | $1 | $120.6K |
| 17107 | Cutaneous vascular destruction is generally performed with a laser (e.g. Argon, pulsed dye, and YAG). This is a bloodless surgery due to the fact that there is no incision made in the skin. This… | 260 | $430 | $110.9K |
| 14021 | The provider repairs lesions in the patient’s scalp, arms, or legs by using the healthy tissues from an adjacent site. This code represents a defect of 10.1 cm2 to 30.0 cm2. | 90 | $850 | $76.5K |
| 17311 | Mohs surgery is a multi–staged procedure that is performed to excise a malignant lesion layer by layer, along with histo–pathological assessment. The assessment is performed to ensure that the… | 220 | $340 | $75.3K |
| 17312 | Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins. | 130 | $400 | $52.1K |
| 14040 | The provider repairs lesions in the patient’s forehead, cheeks, chin, mouth, neck, axillae or armpits, genitalia, hands, and/or feet by using healthy tissues from an adjacent site. This code… | 60 | $740 | $42.4K |
| 14041 | The provider replaces the lesions in the forehead, cheeks, chin, mouth, neck, axillae or armpits, genitalia, hands, or feet with the healthy tissues from an adjacent site. This code represents a… | 50 | $900 | $42.3K |
Showing 1–10 of 30
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 30 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
30 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 17311 | 65 | 150 | 200 | $520 | $136.2K |
| 17107 | 1 | 10 | 260 | $430 | $110.8K |
| 17108 | 1 | 10 | 90 | $610 | $99.9K |
| 17312 | 71 | 140 | 140 | $360 | $65.3K |
| 17313 | 67 | 120 | 80 | $510 | $50.8K |
| 14020 | 12 | 20 | 40 | $640 | $38.9K |
| 96921 | 5 | 10 | 140 | $160 | $36.6K |
| 14021 | 3 | 30 | 20 | $740 | $30.2K |
| 14040 | 11 | 70 | 20 | $650 | $27.4K |
| 14041 | 8 | 50 | 30 | $800 | $22.4K |
Showing 1–10 of 30
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 17108 | Cutaneous vascular destruction is generally performed with a laser (e.g. Argon, pulsed dye, and YAG). This is a bloodless surgery due to the fact that there is no incision made in the skin. This… | 1,390 | $740 | $1M |
| 10160 | The provider inserts a needle into a fluid deposit area on the skin and aspirates fluid or pus to obtain a culture. | 2,530 | $120 | $291.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 4,160 | $70 | $270.7K |
| 67850 | The provider destroys a small lesion of the lid margin, no larger than 1cm, on the area between the front lid edge and back edge of any of the four lids of the eye. | 1,250 | $200 | $246.1K |
| 17360 | The provider uses chemical agents to peel off the acne. | 2,710 | $80 | $213.9K |
| 99243 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a low level of medical decision making or the provider spends at… | 1,260 | $130 | $162.7K |
| 17111 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of 15 lesions or more, other than skin tags or… | 1,520 | $110 | $162.3K |
| 96921 | The provider uses an excimer (ultraviolet) laser to treat the skin disease psoriasis. Use this code for a total treatment area of 250 sq cm to 500 sq cm. | 930 | $170 | $153.4K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 1,530 | $70 | $107K |
| 11901 | This code describes an intralesional injection of a corticosteroid, such as triamcinolone acetonide, for treatment of large nodules, keloids, lichenified hyperkeratotic lesions, and numerous other… | 2,140 | $40 | $83.6K |
Showing 1–10 of 16
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
16 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 17108 | Cutaneous vascular destruction is generally performed with a laser (e.g. Argon, pulsed dye, and YAG). This is a bloodless surgery due to the fact that there is no incision made in the skin. This… | 1 | 10 | 1,390 | $730 | $1M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,995 | 19,110 | 360 | $70 | $321K |
| 17360 | The provider uses chemical agents to peel off the acne. | 12 | 60 | 420 | $110 | $240.8K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 154 | 340 | 260 | $100 | $156.1K |
| 11901 | This code describes an intralesional injection of a corticosteroid, such as triamcinolone acetonide, for treatment of large nodules, keloids, lichenified hyperkeratotic lesions, and numerous other… | 31 | 110 | 450 | $50 | $139.9K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 682 | 4,700 | 130 | $100 | $136.6K |
| 17111 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of 15 lesions or more, other than skin tags or… | 10 | 50 | 290 | $90 | $113K |
| 96921 | The provider uses an excimer (ultraviolet) laser to treat the skin disease psoriasis. Use this code for a total treatment area of 250 sq cm to 500 sq cm. | 4 | 10 | 230 | $130 | $104.2K |
| 10160 | The provider inserts a needle into a fluid deposit area on the skin and aspirates fluid or pus to obtain a culture. | 1 | 10 | 590 | $90 | $87.5K |
| 11900 | This code describes an intralesional injection of a corticosteroid, such as triamcinolone acetonide, for treatment of large nodules, keloids, lichenified hyperkeratotic lesions, and numerous other… | 77 | 200 | 260 | $40 | $83K |
Showing 1–10 of 16
Other providers in the same ZIP code as Bijan Setareh-shenas, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Mid Island Therapy Associates, LLC D/b/a All About Kids | NY | Developmentally Disabled Services Day Training Agency | $0 | $26.9M |
| Central Nassau Guidance & Counseling Services, Inc. | NY | Mental Illness Community Based Residential Treatment Facility | $0 | $26M |
| Acupath Laboratories, Inc. | NY | Clinical Medical Laboratory | $6.5M | $14.8M |
| Renal Focus Asc LLC | NY | Ambulatory Surgical Clinic/Center | $4.2M | $79.6K |
| Peter Brennen | NY | Retina Specialist (Ophthalmology) Physician | $3M | $339.3K |
| Mehran Saboori | NY | Radiation Oncology Physician | $1.5M | $0 |
| Shawn Zimberg | NY | Radiation Oncology Physician | $1.1M | $0 |
| Mohsen Pahlavan | NY | Nephrology Physician | $768.8K | $305K |
| Prem Chatpar | NY | Rheumatology Physician | $939.3K | $5.3K |
| Robert Luntz | NY | Urology Physician | $758.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.